Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/55248
A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
In recent years, the emergence of Staphylococcus aureus strains with reduced susceptibility to glycopeptides has raised considerable concern. We studied the efficacy of vancomycin and teicoplanin, as well as cloxacillin and cefotaxime, against the infection caused by four S. aureus strains with different glycopeptide and β-lactam susceptibilities (strains A, B, C, and D; MICs for vancomycin of 1, 2, 4, and 8 µg/ml respectively), using a modified model of mouse peritonitis. This optimized model appeared to be straightforward and reproducible, and was able to detect low differences in bacterial killing between antibiotics and also between different S. aureus strains. Bactericidal activities in peritoneal fluid for vancomycin, teicoplanin, cloxacillin, and cefotaxime decreased from -2.98, -2.36, -3.22, and -3.57 log10 cfu/ml, respectively, in infection by strain A (MICs for vancomycin and cloxacillin of 1 and 0.38 µg/ml, respectively) to -1.22, -0.65, -1.04, and +0.24 in peritonitis due to strain D (MICs for vancomycin and cloxacillin of 8 and 1,024 µg/ml). Our data confirm the superiority of β-lactams against methicillin-susceptible S. aureus and show that bactericidal activity of glycopeptides decreases significantly with slight increases in MICs; this finding suggests a reduced efficacy of glycopeptides in the treatment of serious glycopeptide-intermediate S. aureus infections
Matèries (anglès)
Citació
Citació
DOMÉNECH ARIZA, Alejandro, RIBES MIRAVET, Sandra, CABELLOS MÍNGUEZ, Ma. carmen, DOMÍNGUEZ LUZÓN, Ma. ángeles (maría ángeles), MONTERO SAEZ, Abelardo, LIÑARES LOUZAO, Josefina, ARIZA CARDENAL, Javier, GUDIOL I MUNTÉ, Francesc. A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections. _Microbial Drug Resistance_. 2004. Vol. 10, núm. 4, pàgs. 346-353. [consulta: 28 de gener de 2026]. ISSN: 1076-6294. [Disponible a: https://hdl.handle.net/2445/55248]